Skip to search.
 TSX Down 0.17% TSX Ventures Down 0.39%

Dyax Corp. (DYAX)

-NasdaqGM
27.97 Down 0.46(1.62%) Apr 17, 4:00PM EDT
|After Hours : 28.00 Up 0.03 (0.11%) Apr 17, 4:44PM EDT
Add to Portfolio
Prev Close:28.43
Open:28.20
Bid:27.97 x 100
Ask:29.33 x 1000
1y Target Est:29.75
Beta:0.49
Next Earnings Date:29-Apr-15DYAX Earnings announcement
Day's Range:27.58 - 28.54
52wk Range:6.05 - 30.55
Volume:1,791,560
Avg Vol (3m):1,824,720
Market Cap:3.83B
P/E (ttm):N/A
EPS (ttm):-0.09
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
DYAXDown 1.62%3.83B
SHPGUp 0.10%47.81B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):47.59
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.18
Quarterly EPS Est (Mar-15) :-0.05
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):-8.49

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Dyax Corp., a biopharmaceutical company, identifies, develops, and commercializes treatments for hereditary angioedema (HAE) and other plasma-kallikrein-mediated (PKM) disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback